Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of investor meetings27-06-2022
27-06-2022
Gland Pharma rides high on valuation comfort, strong growth prospects
Target prices post brokerage upgrades point to more upsides21-06-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of investor meetings17-06-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 79,400 Equity shares under ESOP15-06-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of investor meetings13-06-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of investor meetings08-06-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of the investor meeting06-06-2022
Gland Pharma Ltd - 543245 - Related Party Transactions For The Half Year Ended 31St March 2022
Related Party Transactions for the Half Year Ended 31st March 202231-05-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of the investor meetings30-05-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings call Transcript for Q4FY2226-05-2022